FIELD: HIV treatment.
SUBSTANCE: invention relates to a composition for the treatment of HIV comprising sodium 3'-azido-3'-deoxythymidine-5'-phosphonate (phosphazide) and 3'-(3'-azido-3'-deoxythymidine-5'-phosphonate-3-yl)-3'-deoxythymidine-5'-phosphonate of sodium in an amount from 0.05 to 0.95 wt.%. Also, the present invention relates to a pharmaceutical composition for the treatment of HIV and to a medicament for the treatment of HIV in the form of tablets.
EFFECT: invention provides an increase in the stability (storage time) of the composition in comparison with phosphazide and a decreases in the hygroscopicity of the composition in comparison with phosphazide.
5 cl, 1 dwg, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION WITH ANTI-RETROVIRAL ACTIVITY, PHARMACEUTICAL COMPOSITION AND DRUG | 2020 |
|
RU2806172C1 |
| DERIVATIVES OF 3'-AZIDO-3'-DEOXYTHYMIDINE 5'-H-PHOSPHONATE AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2001 |
|
RU2187509C1 |
| COMBINATION OF ANTIVIRAL AGENTS, KIT AND METHOD OF TREATMENT BASED THEREON | 2018 |
|
RU2726210C2 |
| ANTIVIRAL AGENT (VERSIONS) AND TREATMENT METHOD BASED ON IT | 2005 |
|
RU2331420C2 |
| COMBINED THERAPEUTIC NUTRITIONAL PRODUCT FOR THERAPY OF TK2-ASSOCIATED MITOCHONDRIAL MYOPATHY | 2023 |
|
RU2811769C1 |
| METHOD OF CORRECTING FUNCTIONAL STATE OF TK2-ASSOCIATED MITOCHONDRIAL MYOPATHY | 2023 |
|
RU2811280C1 |
| USE OF THYMIDINE AND DEOXYCYTIDINE AS A COMBINED NUTRITIONAL PRODUCT FOR THE TREATMENT OF TK2-ASSOCIATED MITOCHONDRIAL MYOPATHY | 2023 |
|
RU2811282C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
| METHOD FOR DETERMINING THE AMOUNT OF SESQUITERPENIC ACIDS IN TERMS OF VALERENIC ACID BY HPLC IN PHARMACEUTICALS | 2020 |
|
RU2744231C1 |
| METHOD FOR QUANTITATIVE DETERMINATION OF TAURIN AND ALLANTOINE PRESENT TOGETHER BY HPLC | 2017 |
|
RU2643312C1 |
